NPPB and hydrops fetalis: When compared with eplerenone in HFrEF patients, the ARTS-HF study found similar reductions in proBNP levels between the two drugs, but also hinted at potential benefits of Finerenone in reducing a composite outcome of death, cardiovascular hospitalizations, or emergency presentations, although this finding was exploratory [27].